Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
57,127,897
-
Total 13F shares
-
56,497,918
-
Share change
-
+771,962
-
Total reported value
-
$737,857,014
-
Price per share
-
$13.09
-
Number of holders
-
139
-
Value change
-
+$138,804,594
-
Number of buys
-
92
-
Number of sells
-
61
Institutional Holders of Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) as of Q4 2025
As of 31 Dec 2025,
Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) was held by
139 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,497,918 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BlackRock, Inc., Glazer Capital, LLC, Magnetar Financial LLC, VANGUARD GROUP INC, UBS Group AG, DEUTSCHE BANK AG\, ALLIANCEBERNSTEIN L.P., Balyasny Asset Management L.P., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
139
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.